Observational study of patients with spontaneous intracerebral hemorrhage
Official title: Multicentral Observational Prospective Cohort of Patients With Spontaneous Intracerebral Hemorrhage
Run by First Affiliated Hospital of Fujian Medical University · NCT06670456 · Data updated 2026-11-12
This study is looking at patients with spontaneous brain bleeding to see how they recover and what long-term effects they might have.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | First Affiliated Hospital of Fujian Medical University Academic / other |
| Locations | 6 sites (Fuzhou, Fujian and 5 other locations) |
| Status | Recruiting |
| Started | November 6, 2023 |
| Main results expected | December 31, 2027 |
| Study ends | December 30, 2028 |
| Registry record updated | November 1, 2024 |
| Trial ID | NCT06670456 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals diagnosed with spontaneous intracerebral hemorrhage who have not had any surgical interventions.
✕Probably not a fit
Patients with secondary intracerebral hemorrhage or severe comorbidities that limit life expectancy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicentral, observational, prospective cohort study aims to gather data on patients diagnosed with spontaneous intracerebral hemorrhage (ICH) to assess early outcomes, complications, and long-term neurological and cognitive function. The study will include patients who have not undergone surgical intervention and will analyze cortical data for risk stratification and biomarkers. By following these patients over time, the study seeks to provide insights into the progression and recovery from ICH.
Why it matters
Potential benefit: If successful, this study could improve understanding of ICH outcomes and lead to better risk stratification and management strategies for patients.
How similar studies have gone: While observational studies on ICH exist, this specific approach focusing on cortical data and long-term outcomes is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with spontaneous intracerebral hemorrhage (ICH) through skull radiologic scans (CT or MRI); * Underwent no surgical intervention; Exclusion Criteria: * Secondary intracerebral hemorrhage (with leading cause, e.g., Moyamoya disease, arteriovenous malformation, intracranial aneurysm, tumor, brain trauma) * Pre-stroke life expectancy \< 1 year for severe comorbidities (e.g., Progressive malignant tumor, severe chronic heart failure \[NYHA: III-IV\], severe chronic obstructive pulmonary disease \[III-IV\], chronic kidney disease requiring hemodialysis) * Severe dependency or incorporation to interview (e.g., pre-stroke mRS\>3, severe dementia, intractable mental disease) * Unsuitable for inclusion in the study in the opinion of the investigator
Where it's running
-
First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China Recruiting -
Anxi County Hospital
Quanzhou, Fujian, China Recruiting -
Jinjiang Municipal Hospital
Quanzhou, Fujian, China Recruiting -
The Second Affiliated lospital of Xiamen Medical College
Xiamen, Fujian, China Recruiting -
Zhangzhou Municipal Hospital
Zhangzhou, Fujian, China Recruiting -
Liaocheng People's Hospital
Liaocheng, Shandong, China Recruiting
Study contacts
- Principal investigator: De-zhi Kang, MD — First Affiliated Hospital of Fujian Medical University
- Study coordinator: De-zhi Kang, MD
- Email: kdz99988@vip.sina.com
- Phone: 86 15759413951
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effectiveness of a new neurorehabilitation technology for stroke recovery
This study is testing a new rehabilitation technology that uses robots and virtual reality to see if it can help stroke patients recover better than regular therapy.
-
Emergency Stroke Unit for treating acute strokes
This study is testing a new Emergency Stroke Unit that uses a mobile MRI to see if it can help treat stroke patients faster and improve their recovery.
-
Understanding quality of life and stress in stroke patients and their caregivers
This study looks at how stroke affects the quality of life and stress levels in both patients and their caregivers to see how they compare to people without stroke.
-
Observational study of stroke management and outcomes at Akershus University Hospital
This study looks at how patients with strokes are treated at Akershus University Hospital to see how well different treatments work and why some patients don’t receive certain therapies.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Smartphone-based EEG to detect hidden awareness in ICU patients with brain injuries
Researchers will test a smartphone-enabled EEG to see if it can reveal Cognitive Motor Dissociation in ICU patients who can’t show commands at bedside.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.